Utilize este identificador para referenciar este registo: https://hdl.handle.net/10216/153794
Autor(es): Alshehri, MM
Sharifi-Rad, J
Herrera-Bravo, J
Jara, EL
Salazar, LA
Kregiel, D
Uprety, Y
Akram, M
Iqbal, M
Martorell, M
Torrens-Mas, M
Pons, DG
Dastan, SD
Martins, N
Ozdemir, FA
Kumar, M
Cho, WC
Título: Therapeutic Potential of Isoflavones with an Emphasis on Daidzein
Editor: Hindawi
Data de publicação: 2021
Resumo: Daidzein is a phytoestrogen isoflavone found in soybeans and other legumes. The chemical composition of daidzein is analogous to mammalian estrogens, and it could be useful with a dual-directional purpose by substituting/hindering with estrogen and estrogen receptor (ER) complex. Hence, daidzein puts forth shielding effects against a great number of diseases, especially those associated with the control of estrogen, such as breast cancer, diabetes, osteoporosis, and cardiovascular disease. However, daidzein also has other ER-independent biological activities, such as oxidative damage reduction acting as an antioxidant, immune regulator as an anti-inflammatory agent, and apoptosis regulation, directly linked to its potential anticancer effects. In this sense, the present review is aimed at providing a deepen analysis of daidzein pharmacodynamics and its implications in human health, from its best-known effects alleviating postmenopausal symptoms to its potential anticancer and antiaging properties.
DOI: 10.1155/2021/6331630
URI: https://hdl.handle.net/10216/153794
Fonte: Oxidative Medicine and Cellular Longevity, vol.2021:6331630
Informação Relacionada: info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FPSI-GER%2F28076%2F2017/PT
Tipo de Documento: Artigo em Revista Científica Internacional
Condições de Acesso: openAccess
Licença: https://creativecommons.org/licenses/by/4.0/
Aparece nas coleções:I3S - Artigo em Revista Científica Internacional

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
10.1155-2021-6331630.pdf1.18 MBAdobe PDFThumbnail
Ver/Abrir


Este registo está protegido por Licença Creative Commons Creative Commons